The association between HPV and development of cervical and anal cancer has been well established. HPV infections are more frequent, persistent and difficult to treat in HIV-infected individuals compared to HIV-negative ones. An increased incidence of cervical intraepithelial neoplasia and invasive cervical cancer among HIV-infected women was recognized early in the HIV epidemic however optimal cervical dysplasia/cancer screening among HIV-infected women is still in flux. Anal cancer incidence has been increasing among men and women, especially in HIV-infected individuals. Currently there are no guidelines for routine screening for anal cancer. Screening programs in regions of the United States with high HIV prevalence have been established. The purpose of this workshop is to review current standards for cervical cancer screening as they relate to HIV-infected women and to review screening and management algorithms for men and women living with HIV who may benefit from anal dysplasia screening.
Learning Objectives: